Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

PROMEGA

Promega has a portfolio of more than 3,000 products covering the fields of genomics, protein analysis and expression,... read more Featured Products: More products

Download Mobile App




Long Mononucleotide Repeat Markers Validated for Microsatellite Instability Detection

By LabMedica International staff writers
Posted on 12 Jan 2022
Mismatch repair deficiency (dMMR) predicts response to immune checkpoint inhibitor therapy in solid tumors. More...
Long mononucleotide repeat (LMR) markers may improve the interpretation of microsatellite instability (MSI) assays.

Normally, mismatch repair (MMR) proteins recognize and repair these errors immediately after DNA replication. However, in MMR deficient cells, these errors go unrecognized and remain unrepaired, resulting in novel microsatellite length alleles, or microsatellite instability. dMMR assays are used to screen cancer patients for Lynch syndrome and immune checkpoint inhibitor therapy.

Oncologists at the Johns Hopkins University School of Medicine (Baltimore, MD, USA) included in a study 48 colorectal cancer (CRC) samples, 66 endometrial cancer (EC) samples, 12 pancreatic cancer (PC) samples, and 22 samples of other cancer types, in addition to 12 MSI-low (MSI-L) samples of various cancer types. Macrodissection of tumor and normal tissues was guided by hematoxylin and eosin–stained sections. DNA was then extracted from formalin-fixed, paraffin-embedded tissue using the tissue preparation system (Siemens Healthineers, Erlangen, Germany). DNA concentrations were quantified using the Qubit fluorometer (Invitrogen, Carlsbad, CA, USA).

Immunohistochemistry (IHC) results for MLH1, MSH2, MSH6, and PMS2 proteins were obtained from surgical pathology reports and were used to define MMR status. Antibody clones included anti-MLH1 (clone M1), anti-MSH2 (clone G219-1129), anti-MSH6 (clone SP93), and anti-PMS2 (clone A16-4), all from Roche/Ventana Medical Systems (Tucson, AZ, USA). All IHC assays were performed on the Ventana Benchmark system. Multiplex PCR amplification of five mononucleotide repeat markers and two pentanucleotide repeat markers was performed using the MSI Analysis System V1.2 and the Long Mononucleotide Repeat (LMR) MSI Analysis System (Promega, Madison, WI, USA). Amplification products were analyzed using an ABI 3130×L or ABI 3500×L capillary electrophoresis instrument (Applied Biosystems, Foster City, CA, USA).

The investigators reported that the sensitivity and specificity of the LMR MSI panel for dMMR detection were both 100% in CRC. The sensitivity values of the MSI V1.2 and LMR MSI panels in EC were 88% and 98%, respectively, and the specificity values were both 100%. The sensitivity of the LMR panel was 75% in dMMR prostate cancer detected by immunohistochemistry. The 22 samples of other cancer types that were previously classified as MSI-high (MSI-H) were also classified as MSI-H using the LMR MSI panel. For the 12 samples that were previously classified as MSI-low (MSI-L), one sample was classified as microsatellite stable using the LMR MSI panel, eight as MSI-L, and three as MSI-H.

The authors concluded that the LMR MSI panel showed high concordance to the MSI V1.2 panel in CRC and greater sensitivity in EC. The LMR MSI panel improves dMMR detection in non-colorectal cancers. The study was published on December 02, 2021 in The Journal of Molecular Diagnosis.

Related Links:
Johns Hopkins University School of Medicine
Siemens Healthineers
Invitrogen
Roche/Ventana Medical Systems
Promega
Applied Biosystems



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Collection and Transport System
PurSafe Plus®
New
Clinical Chemistry System
P780
New
Silver Member
PCR Plates
Diamond Shell PCR Plates
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The study highlights the potential of cCAFs as a biomarker for early diagnosis and prognosis (H J Woo et al., Analytical Chemistry (2025). DOI: 10.1021/acs.analchem.5c02154)

Simultaneous Cell Isolation Technology Improves Cancer Diagnostic Accuracy

Accurate cancer diagnosis remains a challenge, as liquid biopsy techniques often fail to capture the complexity of tumor biology. Traditional systems for isolating circulating tumor cells (CTCs) vary in... Read more

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The VENTANA HER2 (4B5) test is now CE-IVDR approved (Photo courtesy of Roche)

Companion Diagnostic Test Identifies HER2-Ultralow Breast Cancer and Biliary Tract Cancer Patients

Breast cancer is the most common cancer in Europe, with more than 564,000 new cases and 145,000 deaths annually. Metastatic breast cancer is rising in younger populations and remains the leading cause... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.